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ABSTRACT
Suppressor of cytokine signaling 3 (SOCS3) is a key regulator of cytokine sig-
naling in macrophages and T cells. Although SOCS3 seems to contribute to the
balance between the pro-inﬂammatory actions of IL-6 family of cytokines and
anti-inﬂammatory signaling of IL-10 by negatively regulating gp130/Jak/Stat3 sig-
nal transduction, how and the molecular mechanisms whereby SOCS3 controls the
downstreamimpactofTLR4arelargelyunknownandcurrentdataarecontroversial.
Furthermore, very little is known regarding SOCS3 function in cells other than
myeloid cells and T cells. Our previous study demonstrates that SOCS3 is expressed
in osteoblasts and functions as a critical inhibitor of LPS-induced IL-6 expression.
However,thefunctionofSOCS3inosteoblastsremainslargelyunknown.Inthecur-
rentstudy,wereportfortheﬁrsttimethatLPSstimulationofosteoblastsinducesthe
transcriptionalactivationofmatrixmetalloproteinase(MMP)-13,acentralregulator
ofboneresorption.Importantly,wedemonstratethatSOCS3overexpressionleadsto
a signiﬁcant decrease of LPS-induced MMP-13 expression in both primary murine
calvariae osteoblasts and a mouse osteoblast-like cell line, MC3T3-E1. Our ﬁndings
implicateSOCS3asanimportantregulatorymediatorinboneinﬂammatorydiseases
bytargetingMMP-13.
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INTRODUCTION
Prolonged inﬂammation is often the reason behind substantial bone loss. In fact,
bacteria-induced inﬂammation is the major cause of bone loss in many bone diseases
such as periodontitis, septic arthritis, and osteomyelitis (Nair et al., 1996; Yip et al., 2004).
MMP-13 is a member of the matrix metalloproteinase family, a group of structurally and
functionally related enzymes responsible for the proteolytic degradation of extracellular
matrix components including collagen ﬁbrils in the bone matrix (Massova et al., 1998;
Woessner, 1991). Among the MMPs expressed in osteoblasts, MMP-13 is predominantly
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al.,1990).ThereislittletonoexpressionofMMP-13innormaladulttissue,astheenzyme
is primarily expressed in hypertrophic chondrocytes, periosteal cells, and osteoblasts
during human fetal development and re-expressed in diseases which require tissue repair
and remodeling (Tardif et al., 2004). This speciﬁc activity of MMP-13, together with
its ability to degrade both type I collagen (the primary extracellular matrix component
secreted by osteoblasts in the trabecular bone) and type II collagen (the primary ﬁbrillar
extracellular matrix component secreted by resting and proliferating chondrocytes in the
growth plate) (Inada et al., 2004; Stickens et al., 2004; Tardif et al., 2004) suggests it to be a
centralagonistofboneresorptionandanimportanttargetininﬂammatorybonediseases.
Supporting this hypothesis, lack of MMP-13-mediated type I collagen degradation could
explain the increased trabecular bone volume in MMP-13 KO mice (Inada et al., 2004;
Stickens et al., 2004; Tardif et al., 2004). On the other hand, increasing evidence suggest
that bone-building osteoblasts stand at the interface between bone turnover and innate
immunity.Ithasbeenreportedthatlipopolysaccharide(LPS)fromEscherichia coli(E. coli)
bacteria up-regulates the expression of several pro-inﬂammatory mediators in osteoblasts
(Nair et al., 1996; Yan et al., 2010), but it is not known whether LPS can induce MMP-13
gene expression in osteoblasts. Given the extensive degradation activity of MMP-13 and
its increased presence in inﬂammatory bone diseases, a better understanding of MMP-13
expression and regulation may lead to therapeutic strategies aimed at inhibiting bone
destruction.
SOCS3 is a SOCS box-containing molecule that inhibits signal transducer and
activator of transcription (STAT)/Janus kinase (JAK) signaling (Babon & Nicola, 2012).
The expression and function of SOCS3 have been investigated mainly in immune cells
including macrophages and T cells. Particularly, SOCS3 expression in T cells has been
showntoregulateonsetandmaintenanceofallergicresponses(Sekietal.,2003).Likewise,
a recent study shows that SOCS3 in macrophages negatively regulates neuroinﬂammatory
responses (Qin et al., 2012). Besides STAT/JAK-dependent cytokines, SOCS3 expression
can also be induced by a variety of other stimuli including TLR ligands (Heeg &
Dalpke, 2003). In fact, SOCS3 is one of the most abundantly induced proteins by LPS in
macrophages(Yoshimura,2009).However,detailedmechanismsbywhichSOCS3regulates
signalingpathwaysdistinctfromSTAT/JAKarestilllargelyunknown.
Expression and function of SOCS3 in bone have also been studied, but investigations
remain in infant stages. Previous studies show that over-expression of SOCS3 suppresses
both acute inﬂammation induced by staphylococcal enterotoxin B/LPS and inﬂammatory
arthritis induced by interleukin-1 (IL-1) or collagen (Shouda et al., 2001; Veenbergen
et al., 2008; Wong et al., 2006). However, due to the embryonic lethality of SOCS3
knockout mice (Roberts et al., 2001), the role of SOCS3 in inﬂammatory bone diseases
remains to be determined. Further, little data is available for the expression and function
of SOCS3 in osteoblasts. Based on our recent study that over-expression of SOCS3
inhibits LPS-induced IL-6 production in osteoblasts (Yan et al., 2010), it is possible
that SOCS3 could down-regulate other pro-inﬂammatory mediators induced by LPS in
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report, we show that LPS stimulation induces a dramatic increase of MMP-13 mRNA
expression in both primary murine calvariae osteoblasts and mouse osteoblast-like cells,
MC3T3-E1.Importantly,ourﬁndingsimplicateanovelroleforSOCS3inthesuppression
ofLPS-inducedMMP-13transcriptioninosteoblasts.
MATERIALS & METHODS
Cell line and reagents
Osteoblast-like MC3T3-E1 cells (American Type Culture Collection, Manassas, VA)
were cultured in -MEM media supplemented with 10% fetal calf serum (FBS) and 1%
Penicillin/Streptomycin(P/S),andmaintainedinahumidiﬁedincubatorat37 Cwith5%
CO2. LPS from Escherichia coli (serotype 0111:B4, Sigma, St. Louis, MO) was obtained
from Sigma. p38 MAP kinase inhibitor VIII was purchased from EMD Biosciences
(Gibbstown, NJ) and dissolved in DMSO for a stock concentration of 50 M. When used
for cell treatment, a 1:5000 dilution was made to achieve a ﬁnal working concentration
of 10 M. For vehicle control, same dilution of DMSO (1:5000) was performed and then
addedtothemedium.
Isolation and culture of primary calvarial osteoblasts
Neonatal mice calvarial osteoblasts were isolated from 3 days old mouse litters by dissec-
tion of the scalp skin and removal of the calvaria as described in a previous publication
(Palmqvist et al., 2002). Calvaria were ﬁrst incubated in -MEM media supplemented
with 10% fetal bovine serum (FBS), 10,000 IU penicillin and 10,000 ug/mL streptomycin,
and then incubated for 10 min in 4 mM Na2EDTA solution 3 times; the supernatants
were discarded. The calvaria were then incubated twice at 37 C with 5% CO2 in a freshly
prepared collagenase type 2 solution containing NaCl, KCl, and NaH2PO4 X H2O on an
orbital shaker; the supernatants were discarded. Then, the digests from ﬁve sequential
incubationswithcollagenasewerepooled,centrifuged,andresuspendedin-MEMmedia
supplemented with 10% FBS, 10,000 IU penicillin, and 10,000 ug/mL streptomycin. Cells
wereplatedin75mlﬂasks.When90%conﬂuencywasreached,thecellswerepassagedinto
24well-platesatadensityof4104 cells/well.
RNA isolation and quantitative real time-polymerase chain reac-
tion (qRT-PCR) analysis
Total cellular RNA were extracted from cells with TRIzol (Invitrogen, Carlsbad,
CA). RNA concentration was determined by Nanodrop spectrophotometer (Wilm-
ington, DE). First-strand cDNA was synthesized from 2 g and 1 g total RNA
from MC3T3-E1 and primary cells, respectively, using the Superscript II RNase
H  Reverse Transcriptase (Invitrogen, Carlsbad, CA). The data were normalized
against glyceraldehyde 3-phosphate dehydrogenase (GAPDH), which was used
as a loading control. PCR was performed with primers for SOCS3: 50 primer,
50-AGCTCCAAAAGCGAGTACCA-30 and30 primer,50-TGACGCTCAACGTGAAGAAG-
30; MMP-13: 50 primer, 50-TGGAGTGCCTGATGTGGGTGAATA-30 and 30 primer,
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50-TGCACCACCAACTGCTTAG-30 and 30 primer, 50-GGATGCAGGGATGATGTTC-30.
The ﬂuorescence of the accumulated double-stranded products was monitored in real
time.Geneexpressionwasdeterminedusingtheequation:“relativeexpression”D 2. 1Ct/,
where1Ct D Ctgene of interest  Ctctrl.
Adenovirus transfection
Construction, ampliﬁcation, and titering of recombinant adenovirus containing mouse
SOCS3 or siRNA for SOCS3 have been described previously (Yan et al., 2010). Brieﬂy,
full-length mouse SOCS3 cDNA was ﬁrst inserted into pDNR-CMV donor vector
resulting in the production of pDNR-CMV-SOCS3, which has loxP sites both upstream
and downstream of the SOCS3 expression cassette. SOCS3 expression cassette was
then transferred from pDNR-CMV-SOCS3 to pLP-Adeno-X-CMV viral DNA using
Cre-loxP recombination (BD Biosciences, Palo Alto, CA), resulting in Adeno-SOCS3. To
generate the virus, Adeno-SOCS3 was digested with PacI and transfected to HEK-293
cells according to the manufacturer’s instructions. Adenoviral siRNA for SOCS3
(Adeno-sh-SOCS3) was generated by Welgen under the control of the cytomegalovirus
promoter. Recombinant adenoviruses were puriﬁed by BD Adeno-X virus puriﬁcation
kit (BD Biosciences, Palo Alto, CA). The viral stocks were tittered using Adeno-X Rapid
Titer Kit (D Biosciences, Palo Alto, CA). MC3T3-E1 cells were grown to 90% conﬂuence
and infected with adenovirus (Adeno-Ctrl, Adeno-SOCS3, or Adeno-sh-SOCS3) at 100
multiplicityofinfection(MOI).Cellswereharvestedforgeneexpressionanalysisafter48h
of transfection. In some groups, the cells were treated with LPS for 6 h prior to harvesting.
TotalRNA wereisolated andreverse-transcribedinto single-strandedcDNAfor qRT-PCR
analysis. In another experiment, MC3T3-E1 cells were treated with LPS for 0, 15, 30, and
60min,respectively,priortoharvesting.Wholecellproteinswereisolatedforwesternblot
analysis.
Western blot analysis
Thecellswerelysedinice-coldradioimmunoprecipitation(RIPA)buVer(FisherScientiﬁc,
Rockford, IL). Following protein extraction, total 80 g of proteins were used to perform
electrophoresis in a 12% polyacrylamide gel and then transferred to a polyvinylidene
ﬂuoride (PVDF) membrane at 25 V for 60 min. Membranes were incubated with rabbit
anti-SOCS3 antibody (Abcam, Cambridge, MA, 1:1000), rabbit anti-p38 antibody (Cell
SignalingTechnology,Danvers,MA,1:1000),orrabbitanti-p-p38antibody(CellSignaling
Technology, Danvers, MA, 1:1000), respectively at 4 C for overnight. After 3 sequential
washes with TBS-T (0.1% Tween), the membranes were incubated with horseradish
peroxidase (HRP)-conjugated mouse anti-rabbit IgG (Fisher Scientiﬁc, Rockford, IL,
1:3000) for 1 h at room temperature. The membranes were developed by enhanced
chemiluminescencetechnique(Pierce,Indianapolis,IN).
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MC3T3-E1 cells were grown to 60–80% conﬂuence and then transfected with indicated
DNA plasmids (0:5 g total) using Fugene 6 Transfection Reagent (Roche, Indianapolis,
IN)asinstructed.Twenty-fourhoursaftertransfection,thecellswereeitherincubatedwith
or without LPS for 4 h. Cell lysates were then collected and analyzed for luciferase activity
byusingtheDual-LuciferaseReporterAssaySystem(Promega,Madison,WI).
Statistical analysis
All data were analyzed using a One-Way ANOVA, and individual group means were then
comparedwithaNewman-Keulstest.
RESULTS
LPS actions on MMP-13 and SOCS3 gene expression in os-
teoblasts
ToassesschangesinMMP-13andSOCS3geneexpressionduringosteoblastinﬂammatory
response, MC3T3-E1 cells were stimulated with LPS for 0, 6, and 24 h; qRT-PCR results
indicatedthatcellsstimulatedwithLPSfor6and24hexhibitedasigniﬁcantincrease(six
foldsforeachtimepoint)ofMMP-13geneexpressionincomparisonwithnon-stimulated
cells (Fig. 1A). Conversely, SOCS3 gene expression was signiﬁcantly reduced 24 h after
LPS stimulation (two folds) (Fig. 1A). In addition, primary calvarial osteoblasts showed
an eight-fold increase in MMP-13 gene expression after stimulation with LPS for 24 h
(Fig.1B);however,LPShadmodestimpactsonSOCS3expression(Fig.1C).
SOCS3 impact on LPS-induced MMP-13 gene expression in os-
teoblasts
We ﬁrst show that over-expression of SOCS3 via transfection with various MOI (50X,
100X, and 200X) adenoviruses carrying the SOCS3 gene causes a signiﬁcant increase
in SOCS3 protein levels in MC3T3-E1 cells (Fig. 2A). Next, we determined whether
SOCS3 expression (100X MOI) in osteoblasts has any impact on LPS-induced MMP-13
expression. As shown in Fig. 2B, MC3T3-E1 cells stimulated with LPS in the presence
of SOCS3 protein exhibited a signiﬁcant decrease (85%, p < 0:001) in MMP-13 gene
expression levels when compared with cells treated with LPS, but transfected with
control viruses. In addition, over-expression of SOCS3 also led to a signiﬁcant decrease
of basal MMP-13 expression (74%, p < 0:001) (Fig. 2B). We evaluate whether SOCS3
knockdownhasanyeVectonLPS-inducedMMP-13expression.Weﬁrstdemonstratethat
adenovirus-mediatedshRNAforSOCS3(Adeno-sh-SOCS3)ledtoasigniﬁcantreduction
of the endogenous SOCS3 expression in MC3T3-E1 cells (>95% reduction compared
with control virus-treated cells) (Fig. 2C). We next show that adeno-sh-SOCS3 infection
of MC3T3-E1 cells resulted in a signiﬁcant augmentation of MMP-13 gene expression
inducedbyLPSstimulationwhencomparedwithcellsinfectedwithcontrolvirus(3.8fold
induction vs 53 fold induction, p < 0:001) (Fig. 2D). These results together implicate an
inhibitoryroleforSOCS3inLPS-inducedMMP-13geneexpressioninosteoblasts.
Gao et al. (2013), PeerJ, DOI 10.7717/peerj.51 5/17Figure 1 LPS induces expression of MMP-13 and SOCS3 in MC3T3-E1 cells and primary calvarial
osteoblasts. MC3T3-E1 cells (A) and primary calvarial osteoblasts (B and C) were incubated with 100 ng
LPS/ml for indicated times. Total cellular RNA was isolated. Oligonucleotide primers used for real time
PCR were MMP-13, SOCS3 and GAPDH. For panel A, data are presented as mean  S. E. M., n D 4–5,
and a representative experiment of a total of two similar experiments is shown.  and  indicate a
statistically signiﬁcant diVerence- p < 0:05 and p < 0:001, respectively.
We next examined the ability of SOCS3 inhibition on MMP-13 expression in primary
calvarial osteoblasts. Consistent with the results from MC3T3-E1 cells, LPS treatment of
Gao et al. (2013), PeerJ, DOI 10.7717/peerj.51 6/17Figure 2 Critical role of SOCS3 in regulating LPS-induced MMP-13 gene expression in MC3T3-E1
cells. (A) MC3T3-E1 cells were infected with Adeno-SOCS3 at indicated MOI. 48 h after infection, the
total protein extracts were subjected to Western blot using antibodies against SOCS3. (B) MC3T3-E1
cells were infected with Adeno-Ctrl or Adeno-SOCS3 at 100 X MOI. 48 h later, the cells were stimulated
either with or without 100 ng LPS/ml for 6 h. Total cellular RNA was isolated. Oligonucleotide primers
used for real time PCR were MMP-13 and GAPDH. Data are presented as mean  S. E. M., n D 4–6.
A representative experiment of a total of three similar experiments is shown.  indicates a statistically
signiﬁcantdiVerence-p<0:001.(C)MC3T3-E1cellswereinfectedwithAdeno-CtrlorAdeno-sh-SOCS3
at a MOI of 100. 48 h after infection, the cells were incubated with 100 ng LPS/ml for 6 h. RNAs were
isolated. Oligonucleotide primers used for real time PCR were SOCS3 and GAPDH. (D) MC3T3-E1 cells
were infected with Adeno-Ctrl or Adeno-sh-SOCS3 at a MOI of 100. 48 h later, cells were incubated
with or without 100 ng LPS/ml for for 6 h. RNAs were isolated. Oligonucleotide primers used for real
time PCR were MMP-13 and GAPDH. Data are presented as mean  S. E. M., n D 4–7. A representative
experiment of a total of two similar experiments is shown.  and  indicate a statistically signiﬁcant
diVerence- p < 0:01 and p < 0:001, respectively.
Gao et al. (2013), PeerJ, DOI 10.7717/peerj.51 7/17Figure 3 Critical role of SOCS3 in regulating LPS-induced MMP-13 gene expression in primary
calvarial osteoblasts. Primary calvarial osteoblasts were infected with Adeno-Ctrl, Adeno-SOCS3, or
Adeno-sh-SOCS3 at 100 X MOI. 48 h later, the cells were stimulated either with or without 100 ng
LPS/ml for 6 h. Total cellular RNA was isolated. Oligonucleotide primers used for real time PCR were
MMP-13andGAPDH.DataarepresentedasmeanS.E.M.,nD6.,,andindicateastatistically
signiﬁcant diVerence-p < 0:05;p < 0:01, and p < 0:001, respectively.
primary calvarial osteoblasts signiﬁcantly induced MMP-13 gene expression (p < 0:001)
(Fig. 3). Importantly, adenovirus-mediated SOCS3 over-expression in primary calvarial
osteoblasts led to a signiﬁcant reduction of MMP-13 expression (44%, p < 0:01) (Fig. 3).
In addition, adeno-sh-SOCS3 infection of primary calvarial osteoblasts resulted in a
signiﬁcant augmentation of MMP-13 gene expression induced by LPS stimulation when
comparedwithcellsinfectedwithcontrolvirus(p < 0:05)(Fig.3).
To further test the ﬁnding that SOCS3 decreases LPS-induced MMP-13 expression
in osteoblasts, we performed a transient transfection assay using MMP-13-promoter
luciferase reporter and SOCS3-expressing plasmid. Twenty-four hours after transfection,
MC3T3-E1 cells were treated with or without LPS for 4 h before harvesting the cells.
Consistent with the results from qRT-PCR (Figs. 2 and 3), LPS stimulation in the absence
of SOCS3-expressing plasmid led to a signiﬁcant increase in luciferase activity compared
with untreated MC3T3-E1 cells (Fig. 4, p < 0:001). The data also indicate that LPS
treatment of SOCS3-transfected MC3T3-E1 cells suppressed luciferase activity over the
reporter alone (Fig. 4, p < 0:05). Furthermore, the group of cells with no LPS treatment
that were transfected with SOCS3-expressing plasmid demonstrated a similar level of
luciferaseactivitywiththatofthecontrolgroup(Fig.4),suggestingthatSOCS3worksonly
inconjugationwithLPSstimulation.
Gao et al. (2013), PeerJ, DOI 10.7717/peerj.51 8/17Figure 4 SOCS3 inhibits the activities of MMP-13 promoter-luciferase induced by LPS. MC3T3-E1
cells were transiently transfected with 0:5 g of DNA comprised of a mouse MMP-13 luciferase gene,
thymidine kinase-luciferase gene, and either SOCS3 expression plasmid or control vector. 24 h after
transfection,thecellswereincubatedwithorwithout100ngLPS/mlfor4h.Celllysateswereusedtoper-
form luciferase activity assay. Luminometer values were normalized for expression from a co-transfected
thymidine kinase reporter gene. The data were expressed as means  S. E. M., n D 3. A representative
experiment of a total of two similar experiments is shown.  and  indicate a statistically signiﬁcant
diVerence- p < 0:05 and p < 0:001, respectively.
SOCS3 inhibits LPS-induced MAP kinase activity in osteoblasts
We next evaluated the potential mechanism (signal pathway) by which SOCS3 suppressed
MMP-13 expression in osteoblasts. All the the mitogen-activated protein kinase (MAPK)
pathways (ERK1/2, p38, and JNK) have been shown to be involved in MMP-13 expression
in response to various stimuli and stress (Nakai et al., 2012; Onodera et al., 2002; Rossa
et al., 2007; Zhang et al., 2012). However, the MAPK pathways which are critical in
the LPS-induced MMP-13 gene regulation remain largely unknown. A previous study
demonstrated that MMP-13 mRNA induction in murine periodontal ligament ﬁbroblasts
byLPSwassigniﬁcantlyreducedbyinhibitionofp38MAPK,suggestingthatLPS-induced
MMP-13 is regulated by p38 signaling (Rossa et al., 2007). Based on this result, we
performed western blot analysis to determine whether SOCS3 may inhibit MMP-13
expression via suppressing p38 MAPK activity in osteoblasts. As shown in Fig. 5A, LPS
induced p38 phosphorylation in MC3T3-E1 cells over the time course of treatment.
Notably, SOCS3 signiﬁcantly inhibited LPS-induced p38 phosphorylation, but has
no major impact on p38 expression (Fig. 5A). Interestingly, SOCS3 had no eVect on
LPS-inducedERK1/2phoshorylationinosteoblasts(datanotshown).
Gao et al. (2013), PeerJ, DOI 10.7717/peerj.51 9/17Figure 5 SOCS3 inhibits LPS-induced MMP-13 expression through p38 MAP Kinase pathway in
MC3T3-E1 cells. (A) MC3T3-E1 cells were infected with Adeno-Ctrl or Adeno-SOCS3 at 100 X MOI.
48 h later, the cells were stimulated either with or without 100 ng LPS/ml for the indicated time periods.
Total proteins were subjected to Western blot by using rabbit (continued on next page...)
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anti-phospho-p38 (p-p38) antibody, rabbit anti-p38 antibody (p38), respectively. (B) Western blot were
digitized and analyzed. p-p38 expression was normalized to p38 expression and the data are presented as
a ratio. (C) MC3T3-E1 cells were infected with Adeno-Ctrl or Adeno-SOCS3 at 100 X MOI. 48 h later,
the cells were stimulated either with or without 100 ng LPS/ml in the presence or absence of p38 MAP
Kinase Inhibitor VII (10 M) or vehicle control (DMSO) for 6 h. Total cellular RNA was isolated for
real time PCR with primers for MMP-13 and GAPDH, respectively. Data are presented as mean  S.
E. M., n D 6. A representative experiment of a total of two similar experiments is shown.  indicate a
statistically signiﬁcant diVerence-p < 0:01.
We next determined the inﬂuence of the p38 phosphorylation on LPS-induced
MMP-13 expression by using speciﬁc pharmacological inhibitors for p38 MAPK. As
shown in Fig. 5B, p38 MAPK inhibitor VIII markedly suppressed osteoblast MMP-13
gene expression induced by LPS. Taken together, these results suggest that p38 MAPK is a
critical signal pathway in LPS-induced MMP-13 gene expression in osteoblasts, which is
inhibitedbySOCS3.
DISCUSSION
Relationships between inﬂammation and bone metabolism have been established
in various clinical settings and animal models of inﬂammatory disease (Hardy &
Cooper, 2009). In particular, inﬂammatory processes surrounding the skeleton aVect
the remodeling of nearby bone tissue, often causing an increase in bone resorption by
osteoclasts (Lerner, 2006). At present, the underlying mechanisms and signaling pathways
by which inﬂammation impacts bone architecture remain poorly understood. Moreover,
little is known regarding the downstream activities in osteoblasts following bacterial
infection. LPS is a component of the outer membrane of gram-negative bacteria and
elicits potent immune responses in animals (Gao et al., 2007; Kadono et al., 1999; Orcel
et al., 1993). LPS stimulation constitutes the initial step in a cascade of events that can
lead to diseases caused by gram-negative bacterial infections, such as sepsis (Chow et
al., 1999). It has been reported that LPS modulates bone resorption by regulating the
activities of both osteoblasts and osteoclasts (Xing et al., 2011). Speciﬁcally, LPS promotes
pre-osteoclastactivityviabindingtotoll-likereceptor4(TLR4).DiVerentiatedosteoblasts
alsoexpressfunctionalTLR4,whichseemstoplayanimportantroleinthepathogenesisof
LPS-induced bone disorders (Cassatella et al., 1999; Inada et al., 2006; Kikuchi et al., 2001;
Takamietal.,2002).Arecentstudyshowedthatoptimalosteoclastogenesisin vitrorequires
TLR4 expression in both bone marrow monocytes and osteoblasts (Zhuang et al., 2007),
suggesting that bacterial stimuli such as LPS work explicitly through TLR4. However,
detailed signaling pathways following LPS binding to TLR4 on osteoblasts have yet to be
elucidated. While LPS signaling in macrophages and osteoclasts have been extensively
studied,itsexactroleinosteoblastsremainslargelyunknown.
LPS stimulation of MMP-13 transcriptional expression in os-
teoblasts
In this study, we investigated the impact of LPS on the transcriptional activation of
MMP-13, a central regulator of bone resorption, in osteoblasts. As shown in Figs. 1–4,
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exhibit signiﬁcant increases in MMP-13 mRNA expression upon stimulation with E.
coli LPS. This is the ﬁrst report showing E. coli LPS induction of MMP-13 expression
in mouse osteoblasts thus far. During the reviewing of this manuscript, Barnes et al.
published a report showing that triclosan inhibits LPS-induced MMP-13 expression in
a rat osteoblastic osteosarcoma cell line (Barnes et al., 2013). However, the source of
LPS used in this study is not known. The up-regulatory actions of LPS on MMP-13, an
enzyme exclusively present in fetal skeletal development and in certain diseases involving
bone resorption, suggests MMP-13 to be a key bone-resorbing perpetrator expressed
by osteoblasts in inﬂammatory bone diseases. Taken together with previously reported
LPS-induction of inﬂammatory mediators in osteoblasts (Nair et al., 1996), this ﬁnding
strengthens the understanding of osteoblast-mediated immune response conveyed in
inﬂammatorybonediseases.
Role of SOCS3 in LPS-induced MMP-13 expression
The role of SOCS3 in inﬂammation is complex and has been a popular topic in both
innate and adaptive immunity ﬁelds during the past decade. Research surrounding
SOCS3 has also been controversial, as both pro- and anti-inﬂammatory functions of
SOCS3 have been demonstrated. For example, SOCS3 plays a critical role in preventing
interferon- (IFN-)-like responses in cells stimulated by IL-6 (Croker et al., 2003; Lang
et al., 2003), which promotes both acute and chronic inﬂammation in the absence of
SOCS3 in vivo (Croker et al., 2012). Conversely, mice lacking SOCS3 in neutrophils and
macrophages are resistant to LPS-induced shock, indicating that SOCS3 may function as
a pro-inﬂammatory mediator by suppressing IL-6 signaling, interfering with its ability to
inhibitLPSsignaling(Sekietal.,2003;Yasukawaetal.,2003).Thisconclusionissupported
by a recent report showing that SOCS3 promotes TLR4 response in macrophages by
feedback inhibiting TGF1 signaling (Liu et al., 2008). Thus, understanding the roles
of SOCS3 in various diseases is critical to revealing insights into signaling pathways that
canbemanipulatedinpotentialtherapeuticapproaches.
SOCS3 is expressed in all major bone cells including osteoclasts, chondrocytes, and
osteoblasts (Ohishi et al., 2005; van de Loo et al., 2012; Yan et al., 2010). Interestingly,
a recent study demonstrated that SOCS3 is highly expressed in human arthritic
chondrocytes and aVects the production of nitric oxide (NO) and proteoglycans
(van de Loo et al., 2012). In addition, this study shows that there is a strong positive
correlation between SOCS3 expression and that of genes that are putatively involved in
the arthritic process including MMP13. Thus, they propose that SOCS3 could play a
centralroleinthepathophysiologyofjointdiseasesbyderegulatingchondrocytefunction.
However, investigation of the SOCS3 function in the bone remodeling system, speciﬁcally
in osteoblasts, is still in its early stages. Our current study shows that over-expression of
SOCS3drasticallydown-regulatesLPS-inducedMMP-13geneexpressioninbothprimary
murine calvariae osteoblasts and MC3T3-E1 cells (Figs. 2 and 4). Furthermore, SOCS3
knockdown leads to a signiﬁcant increase of LPS-induced MMP-13 gene expression in
Gao et al. (2013), PeerJ, DOI 10.7717/peerj.51 12/17MC3T3-E1 cells (Fig. 3). These ﬁndings strengthen the characterization of SOCS3 as an
anti-inﬂammatorysignalingmoleculeinosteoblast-mediatedimmuneresponses.
As shown in Fig. 1A, endogenous levels of SOCS3 decreases continuously following
E. coli LPS stimulation while MMP-13 expression signiﬁcantly increases at 6 and 24 h
following E. coli LPS treatment. Thus, in order to eVectively suppress E. coli LPS-induced
MMP-13 transcription, an adequate expression of SOCS3 may be necessary. Additionally,
otherunknownmoleculesmaybeinvolvedinthedown-regulationofMMP-13expression
at48hafterE. coliLPStreatmentsinceSOCS3expressionisalsoverylowatthistimepoint
(datanotshown).
MMP-13 expression can be regulated by MAPK in response to various stimuli and in
diVerentcells(Nakaietal.,2012;Onoderaetal.,2002;Rossaetal.,2007;Zhangetal.,2012).
However, how SOCS3 regulates MAPK in osteoblast is not known. Using p38 MAP kinase
inhibitor, a previous study shows that LPS-stimulated MMP-13 mRNA induction was
signiﬁcantly reduced by inhibition of p38 MAP kinase in murine periodontal ligament
ﬁbroblasts. Thus, our results that LPS treatment led to the phosphorylation of p38 MAP
kinase is consistent with this report (Rossa et al., 2007). Importantly, our results suggest
that SOCS3 plays a critical role in LPS-induced MMP-13 gene expression in osteoblast by
regulating p38 MAPK pathway. However, the molecular details of SOCS3 regulation of
signalingpathwaysdownstreamofTLR4inosteoblastsremaintobedetermined.
CONCLUSIONS
We show that LPS signiﬁcantly increases MMP-13 mRNA expression in both primary
murine calvariae osteoblasts and osteoblast-like cells, MC3T3-E1. These ﬁndings together
with related bone inﬂammation literature (Nair et al., 1996; Yan et al., 2010), enhance
the connection between the bone remodeling process and inﬂammation. In addition, we
identify a novel regulatory role of SOCS3 in osteoblast-mediated inﬂammatory responses
in MC3T3-E1 cells: through over-expression and knockdown of SOCS3 protein, we
demonstrate,fortheﬁrsttime,thatSOCS3suppressesMMP-13transcriptionalactivation
following LPS stimulation in osteoblasts. Exploring the underlying mechanisms and
signaling pathways regulating SOCS3 expression in osteoblasts could lead to important
new knowledge involving therapeutic targeting of MMP-13 in inﬂammation-resolving
approaches.
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